CakeResume
CakeResume Logo
Log In
Sign Up
Build your Network
My Network
Access your personal network connections and manage your contacts.
CakeResume Meet
Expand your professional network by meeting and connecting with other users.
Community
Engage with other users through discussions, forums, and networking events.
Log In
Sign Up
Avatar of Duane Boise.
Duane Boise
President @ MMJ BioPharma Labs
ProfileResumePortfolio
Posts
0Connections
Print
Avatar of the user.

Duane Boise

President @ MMJ BioPharma Labs
Duane Boise, President of MMJ companies is building a center of marijuana excellence in Rhode Island MMJ has filed for FDA sanctioned clinical trials in Multiple Sclerosis and Huntington's Disease. MMJ was awarded the much coveted Orphan Designation from the FDA for its planned Huntington's Disease trials. MMJ has also received a DEA schedule 1 analytical cannabis lab license. The company is awaiting imminent final DEA award to cultivate its strain specific marijuana as a pharmaceutical to supply these clinical trials.
MMJ BioPharma Labs
United States

Professional Background

  • Current status
  • Profession
  • Fields
  • Work experience
    More than 15 years
  • Management
  • Skills
    leadership
    Leadership + Management
    Research
    Technological Innovation
    Executive Management
    Medical Devices
    Computer Science
    Electronic Medical Record (EMR)
    Biotechnology
    Public Speaking
    Sales & Customer Service
    Social Media
    Functional Genomics
    Computational Modeling
    Computational Genomics
    Technology Software
  • Highest level of education

Job search preferences

  • Desired job type
    Not interested in working remotely
  • Desired positions
  • Desired work locations
  • Freelance

Work Experience

President

MMJ BioPharma Labs
・
Full-time
Jan 2021 - Present
Westerly, RI, USA
MMJ International Holdings will assist MMJ Biopharma Labs in the research and development of its proprietary cannabis Gel Cap drug for FDA approval or the treatment of multiple sclerosis and Huntington’s disease. MMJ Biopharma Labs is a schedule 1 licensed analytical lab. Duane Boise, president of the company remarked, "With the sophistication of this advanced precision cultivation and monitoring technology, MMJ will be able to reproduce quality cannabis, thus meeting the DEA's marijuana definition of chemical reproducibility and quality.

President CEO

MMJ International Holdings
・
Full-time
Jan 2016 - Present
Westerly, RI, USA
MMJ International Holdings will assist MMJ Biopharma Labs in the research and development of its proprietary cannabis Gel Cap drug for FDA approval or the treatment of multiple sclerosis and Huntington’s disease. MMJ Biopharma Labs is a schedule 1 licensed analytical lab. Duane Boise, president of the company remarked, "With the sophistication of this advanced precision cultivation and monitoring technology, MMJ will be able to reproduce quality cannabis, thus meeting the DEA's marijuana definition of chemical reproducibility and quality.

President

MMJ BioPharma Cultivation
・
Full-time
Jan 2016 - Present
Westerly, RI, USA
MMJ International Holdings will assist MMJ Biopharma Labs in the research and development of its proprietary cannabis Gel Cap drug for FDA approval or the treatment of multiple sclerosis and Huntington’s disease. MMJ Biopharma Labs is a schedule 1 licensed analytical lab. Duane Boise, president of the company remarked, "With the sophistication of this advanced precision cultivation and monitoring technology, MMJ will be able to reproduce quality cannabis, thus meeting the DEA's marijuana definition of chemical reproducibility and quality.

Education

No content as of now.

Licenses & Certifications

DEA Schedule 1 Registration

Drug Enforcement Administration
Issued Jan 2022
・
No Expiration Date